Research news

Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

UCLH now has 24 active Covid-19 research studies – up from nine at the beginning of the month – with another 9 under consideration or being set up.

Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.